Nanomix launches trial of eLab analyzer and panel

By staff writers

June 23, 2022 -- Nanomix has launched a trial in Spain to evaluate its eLab mobile immunoassay diagnostic system and S1 Panel assay for the detection of critical infections.

The company's eLab system is a mobile, handheld immunoassay and chemistry diagnostic system designed for rapid point-of-care testing, while the S1 Panel Cartridge was developed to aid in diagnosing critical infections, including sepsis. The panel provides quantitative test results for procalcitonin (PCT), C-reactive protein (CRP), and lactate (LAC) from a single venous whole blood or plasma sample type.

The trial will be conducted at the emergency department of Hospital Clinico San Carlos in Madrid.

Nanomix receives IVDR certification for eLab analyzer
Point-of-care diagnostics firm Nanomix on Tuesday announced it has received the EU Quality Management System Certificate under the new In Vitro Diagnostic...
Nanomix seeks EUA for COVID-19 rapid antigen panel
Nanomix has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for its eLab COVID-19 rapid antigen test, which runs...
Nanomix mobile, 3-in-1 sepsis test gets CE Mark
Nanomix announced that its S1 assay for serious infections, including sepsis and bacteremia, has received the CE Mark, paving the way for sales in European...

Copyright © 2022

Last Updated mp 6/23/2022 12:53:35 PM